Aquestive Therapeutics, Inc. (AQST) Revenue by Year
Aquestive Therapeutics, Inc. generated $44.5M in revenue in fiscal year 2025. This represents a decrease of 22.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $54.1M in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Aquestive Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AQST Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
AQST Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Aquestive Therapeutics, Inc. financials
Frequently Asked Questions
What was Aquestive Therapeutics, Inc.'s revenue in fiscal year 2025?
Aquestive Therapeutics, Inc. generated $44.5M in revenue in fiscal year 2025.
How fast is Aquestive Therapeutics, Inc.'s revenue growing?
Aquestive Therapeutics, Inc. (AQST) revenue fell by 22.6% year over year, from $57.6M to $44.5M in fiscal year 2025.
What is Aquestive Therapeutics, Inc.'s revenue over the last twelve months?
Aquestive Therapeutics, Inc. (AQST) reported $54.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Aquestive Therapeutics, Inc.'s revenue changed over the years?
Across the 9 fiscal years this page covers, Aquestive Therapeutics, Inc. (AQST) revenue went from $66.9M in fiscal year 2017 to $44.5M in fiscal year 2025.
What was Aquestive Therapeutics, Inc.'s revenue in the most recent quarter?
Aquestive Therapeutics, Inc. (AQST) reported $13.8M in revenue in Q2 2026. This represents an increase of 38.1% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Aquestive Therapeutics, Inc. (AQST) reported on that line in every period on record.